metoprolol has been researched along with Cytokine Release Syndrome in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Y | 1 |
| Zhang, Y | 1 |
| Xing, X | 1 |
| Xu, G | 1 |
| Lin, X | 1 |
| Wang, Y | 1 |
| Chen, M | 1 |
| Wang, C | 1 |
| Zhang, B | 1 |
| Han, W | 1 |
| Hu, X | 1 |
1 other study available for metoprolol and Cytokine Release Syndrome
| Article | Year |
|---|---|
IL-6 translation is a therapeutic target of human cytokine release syndrome.
Topics: Cytokine Release Syndrome; Cytokines; Humans; Immunotherapy, Adoptive; Interleukin-6; Metoprolol; Re | 2023 |